Electronic Structure and Redox of the Antidepressants Venlafaxine and Desvenlafaxine

Venlafaxine and its primary metabolite desvenlafaxine are antidepressants that block presynaptic reuptake of serotonin and norepinephrine in the brain. Electroanalytical and computational analyses were performed to evaluate the electrochemical characterization of these drugs through measurements usi...

全面介紹

Saved in:
書目詳細資料
主要作者: Jhon Kennedy Alves Pereira (22681627) (author)
其他作者: Eufrásia de Sousa Pereira (22681630) (author), Bárbara Júlia Gonçalves Dutra (22681633) (author), Isaac Yves Lopes de Macêdo (22681636) (author), Arthur Saldanha Guimarães (22681639) (author), Bruno Junior Neves (5960789) (author), Eric de Souza Gil (6303956) (author), Freddy Fernandes Guimarães (6293438) (author)
出版: 2025
主題:
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Venlafaxine and its primary metabolite desvenlafaxine are antidepressants that block presynaptic reuptake of serotonin and norepinephrine in the brain. Electroanalytical and computational analyses were performed to evaluate the electrochemical characterization of these drugs through measurements using a carbon paste electrode alongside quantum calculations (DFT and TD–DFT) to support the electrochemical data and propose potential oxidation pathways. The results showed that both venlafaxine and desvenlafaxine exhibit different pH-dependent electrochemical behaviors, with desvenlafaxine showing higher anodic peak intensities at neutral pH, while venlafaxine peaks at alkaline pH. Computational insights from DFT calculations provided a deeper understanding of the molecular charge distribution, orbital profiles, and energetics of both drugs in neutral and protonated states. The Gibbs free energy variations in different medium environments revealed the critical role of the medium in modulating the thermodynamic stability. These findings presented here improve our understanding of the electrochemical and electronic properties of these antidepressants and may pave the way for the development of more effective therapeutic agents.